ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/07/19 | 3,785 | 3,895 | 3,740 | 3,835 | +50 | +1.3% | 120,800 |
| 2018/07/18 | 3,650 | 3,820 | 3,650 | 3,785 | +135 | +3.7% | 113,700 |
| 2018/07/17 | 3,660 | 3,715 | 3,640 | 3,650 | -45 | -1.2% | 75,400 |
| 2018/07/13 | 3,700 | 3,730 | 3,655 | 3,695 | +20 | +0.5% | 75,500 |
| 2018/07/12 | 3,640 | 3,705 | 3,610 | 3,675 | +65 | +1.8% | 66,400 |
| 2018/07/11 | 3,650 | 3,680 | 3,530 | 3,610 | -95 | -2.6% | 139,000 |
| 2018/07/10 | 3,730 | 3,765 | 3,655 | 3,705 | +20 | +0.5% | 119,000 |
| 2018/07/09 | 3,780 | 3,875 | 3,625 | 3,685 | -95 | -2.5% | 238,000 |
| 2018/07/06 | 3,630 | 3,780 | 3,575 | 3,780 | +265 | +7.5% | 301,200 |
| 2018/07/05 | 3,845 | 3,935 | 3,450 | 3,515 | -385 | -9.9% | 479,900 |
| 2018/07/04 | 4,075 | 4,075 | 3,780 | 3,900 | -185 | -4.5% | 351,600 |
| 2018/07/03 | 4,590 | 4,630 | 4,065 | 4,085 | -475 | -10.4% | 297,000 |
| 2018/07/02 | 4,885 | 4,885 | 4,555 | 4,560 | -325 | -6.7% | 121,900 |
| 2018/06/29 | 4,745 | 4,885 | 4,705 | 4,885 | +125 | +2.6% | 67,500 |
| 2018/06/28 | 4,800 | 4,805 | 4,700 | 4,760 | -85 | -1.8% | 86,900 |
| 2018/06/27 | 4,870 | 4,930 | 4,655 | 4,845 | +4,356 | +890.8% | 107,400 |
| 2018/06/26 | 466 | 490 | 464 | 489 | +13 | +2.7% | 836,000 |
| 2018/06/25 | 498 | 501 | 476 | 476 | -25 | -5% | 1,205,000 |
| 2018/06/22 | 507 | 510 | 499 | 501 | -13 | -2.5% | 1,310,000 |
| 2018/06/21 | 512 | 518 | 509 | 514 | +2 | +0.4% | 1,301,000 |
| 2018/06/20 | 504 | 513 | 496 | 512 | +7 | +1.4% | 1,653,000 |
| 2018/06/19 | 502 | 508 | 496 | 505 | +2 | +0.4% | 1,654,000 |
| 2018/06/18 | 508 | 515 | 500 | 503 | +2 | +0.4% | 1,586,000 |
| 2018/06/15 | 510 | 512 | 499 | 501 | -2 | -0.4% | 1,004,000 |
| 2018/06/14 | 517 | 521 | 502 | 503 | -6 | -1.2% | 1,498,000 |
| 2018/06/13 | 504 | 516 | 500 | 509 | +9 | +1.8% | 1,591,000 |
| 2018/06/12 | 479 | 511 | 479 | 500 | +24 | +5% | 3,070,000 |
| 2018/06/11 | 471 | 480 | 470 | 476 | +3 | +0.6% | 1,132,000 |
| 2018/06/08 | 470 | 477 | 466 | 473 | +8 | +1.7% | 1,270,000 |
| 2018/06/07 | 468 | 481 | 464 | 465 | +11 | +2.4% | 2,585,000 |
| 2018/06/06 | 452 | 464 | 450 | 454 | -6 | -1.3% | 1,142,000 |
| 2018/06/05 | 456 | 464 | 450 | 460 | +2 | +0.4% | 1,359,000 |
| 2018/06/04 | 459 | 461 | 453 | 458 | +2 | +0.4% | 921,000 |
| 2018/06/01 | 451 | 461 | 451 | 456 | -1 | -0.2% | 1,060,000 |
| 2018/05/31 | 464 | 468 | 447 | 457 | -2 | -0.4% | 2,080,000 |
| 2018/05/30 | 465 | 472 | 457 | 459 | -16 | -3.4% | 1,927,000 |
| 2018/05/29 | 481 | 483 | 464 | 475 | -4 | -0.8% | 1,723,000 |
| 2018/05/28 | 485 | 493 | 479 | 479 | -3 | -0.6% | 1,291,000 |
| 2018/05/25 | 501 | 504 | 480 | 482 | -19 | -3.8% | 2,258,000 |
| 2018/05/24 | 509 | 511 | 501 | 501 | -9 | -1.8% | 946,000 |
| 2018/05/23 | 512 | 519 | 507 | 510 | -2 | -0.4% | 1,333,000 |
| 2018/05/22 | 503 | 513 | 499 | 512 | +11 | +2.2% | 1,890,000 |
| 2018/05/21 | 498 | 504 | 496 | 501 | +1 | +0.2% | 1,435,000 |
| 2018/05/18 | 505 | 512 | 498 | 500 | -10 | -2% | 1,550,000 |
| 2018/05/17 | 503 | 512 | 498 | 510 | +9 | +1.8% | 1,487,000 |
| 2018/05/16 | 510 | 515 | 495 | 501 | -9 | -1.8% | 1,990,000 |
| 2018/05/15 | 515 | 527 | 504 | 510 | +1 | +0.2% | 2,294,000 |
| 2018/05/14 | 528 | 560 | 509 | 509 | -29 | -5.4% | 5,029,000 |
| 2018/05/11 | 537 | 547 | 529 | 538 | +1 | +0.2% | 1,350,000 |
| 2018/05/10 | 551 | 556 | 536 | 537 | -12 | -2.2% | 1,560,000 |
1651～
1700
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 223,700円 | +21.7% | +999.9% | 0.00% | 9.32倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.39倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 311,000円 | +3.0% | +27.5% | 2.57% | 19.69倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 149,500円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 225,100円 | +0.4% | -8.4% | 2.35% | 28.90倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
